North American Scientific Inc. reported that the company lost $3.2 million or $0.11 per share for its fiscal second quarter ended April 30 on revenues of $6.2 million. The Chatsworth-based developer of radiation therapy products noted that revenues in its core business, radiation sources, grew by 19 percent compared with the fiscal second quarter of last year, and gross profit in the division increased 45 percent over last year. The company reported a net loss of $3.7 million or $0.22 per share in the fiscal 2006 period on revenues of $5.8 million. North American Scientific said that it expects to begin clinical work with its ClearPath, breast brachytherapy device at the end of this fiscal year.
